Iodofiltic acid I-123 - Medco Research

Drug Profile

Iodofiltic acid I-123 - Medco Research

Alternative Names: Iodophenylpentadecanoic acid I-123; ViaScint

Latest Information Update: 12 Apr 1999

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator King Pharmaceuticals Research and Development
  • Class Fatty acids; Imaging agents; Iodinated contrast media; Iodobenzenes; Small molecules
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Coronary disorders

Most Recent Events

  • 12 Apr 1999 Discontinued - Preregistration for Coronary disorders diagnosis in USA (unspecified route)
  • 22 Nov 1996 Preregistration for Coronary disorders diagnosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top